Biến chứng của bệnh to đầu chi: tuyến giáp và đại tràng

Cohen P, Clemmons DR, Rosenfeld RG et al (2000) Does the GH–IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10:297–305. doi:10.1054/ghir.2000.0171 Boguszewski CL, Ayuk J (2016) Management of endocrine disease: acromegaly and cancer: an old debate revisited. Eur J Endocrinol. doi:10.1530/EJE-16-0178 Renehan AG, Zwahlen M, Minder C et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (London, England) 363:1346–1353. doi:10.1016/S0140-6736(04)16044-3 Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86:2935–2941. doi:10.1210/jcem.86.7.7634 Melmed S (2001) Acromegaly and cancer: Not a problem? J Clin Endocrinol Metab 86:2929–2934. doi:10.1210/jcem.86.7.7635 Roelfsema F, Biermasz NR, Frolich M et al (2009) Diminished and irregular thyrotropin secretion with preserved diurnal rhythm in patients with active acromegaly. J Clin Endocrinol Metab 94:1945–1950. doi:10.1210/jc.2009-0174 Miyakawa M, Saji M, Tsushima T et al (1988) Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor 1 levels. J Clin Endocrinol Metab 67:973–978 Lamberg BA, Pelkonen R, Aro A, Grahne B (1976) Thyroid function in acromegaly before and after transsphenoidal hypophysectomy followed by cryoapplication. Acta Endocrinol (Copenh) 82:254–266 Geelhoed-Duijvestijn PH, Roelfsema F, Schröder-van der Elst JP et al (1992) Effect of administration of growth hormone on plasma and intracellular levels of thyroxine and tri-iodothyronine in thyroidectomized thyroxine-treated rats. J Endocrinol 133:45–49 Damjanović SS, Petakov MS, Raicević S et al (2000) Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery. J Clin Endocrinol Metab 85:147–154. doi:10.1210/jcem.85.1.6296 Gøtzsche LS, Flyvbjerg A, Marshall S et al (1991) The influence of growth hormone and thyroxine on iodothyronine deiodinase activity in the liver, kidney and brown adipose tissue in hypophysectomized rats. Acta Endocrinol (Copenh) 125:219–226 Roelfsema F, Frölich M (1991) Pulsatile thyrotropin release and thyroid function in acromegalics before and during subcutaneous octreotide infusion. J Clin Endocrinol Metab 72:77–82. doi:10.1210/jcem-72-1-77 Wuster C, Steger G, Schmelzle A et al (1991) Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res 23:131–134. doi:10.1055/s-2007-1003632 Gasperi M, Martino E, Manetti L et al (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25:240–245. doi:10.1007/BF03343997 Marzullo P, Cuocolo A, Ferone D et al (2000) Cardiac effect of thyrotoxicosis in acromegaly. J Clin Endocrinol Metab 85:1426–1432. doi:10.1210/jc.85.4.1426 Chanson P, Salenave S, Kamenicky P et al (2009) Acromegaly. Best Pract Res Clin Endocrinol Metab 23:555–574. doi:10.1016/j.beem.2009.05.010 Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152. doi:10.1210/er.2002-0022 Katznelson L, Laws ER, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933–3951. doi:10.1210/jc.2014-2700 Gatto F, Barbieri F, Castelletti L et al (2011) In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5. Pituitary 14:141–147. doi:10.1007/s11102-010-0271-2 Lamberts SW, Zuyderwijk J, den Holder F et al (1989) Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells. Neuroendocrinology 50:44–50 Amlashi FG, Tritos NA (2016) Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management. Endocrine. doi:10.1007/s12020-016-0863-3 Atkinson H, England JA, Rafferty A et al (2013) Somatostatin receptor expression in thyroid disease. Int J Exp Pathol 94:226–229. doi:10.1111/iep.12024 Razzore P, Colao A, Baldelli R et al (1999) Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective study. Clin Endocrinol (Oxf) 51:159–164. doi:10.1046/j.1365-2265.1999.00812.x Carvalho P, Lau E, Carvalho D (2015) Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results. Pituitary 18:844–860. doi:10.1007/s11102-015-0661-6 Sarkar S, Rajaratnam S, Chacko G, Chacko AG (2014) Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly. Clin Neurol Neurosurg 126:190–195. doi:10.1016/j.clineuro.2014.09.004 Berkmann S, Fandino J, Müller B et al (2012) Pituitary surgery: experience from a large network in Central Switzerland. Swiss Med Wkly 142:w13680. doi:10.4414/smw.2012.13680 Haugen BR, Alexander EK, Bible KC et al (2015) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. doi:10.1089/thy.2015.0020 Tode B, Serio M, Rotella CM et al (1989) Insulin-like growth factor-I: autocrine secretion by human thyroid follicular cells in primary culture. J Clin Endocrinol Metab 69:639–647 Cheung NW, Boyages SC (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46:545–549. doi:10.1046/j.1365-2265.1997.1680985.x Yoshinari M, Tokuyama T, Kuroda T et al (1992) Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotrophin. Clin Endocrinol (Oxf) 36:355–360 Wolinski K, Czarnywojtek A, Ruchala M (2014) Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly—meta-analysis and systematic review. PLoS ONE. doi:10.1371/journal.pone.0088787 Dagdelen S, Cinar N, Erbas T (2014) Increased thyroid cancer risk in acromegaly. Pituitary 17:299–306. doi:10.1007/s11102-013-0501-5 Balkany C, Cushing GW (1995) An association between acromegaly and thyroid carcinoma. Thyroid 5:47–50. doi:10.1089/thy.1995.5.47 Dos Santos MCC, Nascimento GC, Nascimento AGC et al (2013) Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 16:109–114. doi:10.1007/s11102-012-0383-y Herrmann BL, Baumann H, Janssen OE et al (2004) Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Exp Clin Endocrinol Diabetes 112:225–230. doi:10.1055/s-2004-817967 de Uchoa HBDMP, Lima GAB, Corrêa LL et al (2013) Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center. Arq Bras Endocrinol Metabol 57:685–690 Gullu BE, Celik O, Gazioglu N, Kadioglu P (2010) Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13:242–248. doi:10.1007/s11102-010-0224-9 Popovic V, Damjanovic S, Micic D et al (1998) Increased incidence of neoplasia in patients with pituitary adenomas. Clin Endocrinol (Oxf) 49:441–445. doi:10.1046/j.1365-2265.1998.00536.x Barzilay J, Heatley GJ, Cushing GW (1991) Benign and malignant tumors in patients with acromegaly. Arch Intern Med 151:1629–1632 Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322. doi:10.1001/jamaoto.2014.1 Ito Y, Miyauchi A (2015) Nonoperative management of low-risk differentiated thyroid carcinoma. Curr Opin Oncol 27:15–20. doi:10.1097/CCO.0000000000000143 Renehan AG, Painter JE, Bell GD et al (2005) Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy. Clin Endocrinol (Oxf) 62:323–330. doi:10.1111/j.1365-2265.2005.02217.x Wassenaar MJE, Cazemier M, Biermasz NR et al (2010) Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. J Clin Endocrinol Metab 95:2073–2079. doi:10.1210/jc.2009-1714 Dutta P, Bhansali A, Vaiphei K et al (2012) Colonic neoplasia in acromegaly: Increased proliferation or deceased apoptosis? Pituitary 15:166–173. doi:10.1007/s11102-011-0300-9 Bogazzi F, Ultimieri F, Raggi F et al (2002) Peroxisome proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients. J Clin Endocrinol Metab 87:2403–2406. doi:10.1210/jcem.87.5.8625 Krzentowska A, Gołkowski F, Bałdys-Waligórska A, Hubalewska-Dydejczyk A (2010) [Gastrointestinal tract polyps in acromegaly patients]. Przegla̧d Lek 67:1266–1269 Rokkas T, Pistiolas D, Sechopoulos P et al (2008) Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol 14:3484–3489 Lois K, Bukowczan J, Perros P et al (2015) The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines. Pituitary 18:568–574. doi:10.1007/s11102-014-0586-5 Dworakowska D, Gueorguiev M, Kelly P et al (2010) Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines. Eur J Endocrinol 163:21–28. doi:10.1530/EJE-09-1080 Ron E, Gridley G, Hrubec Z et al (1991) Acromegaly and gastrointestinal cancer. Cancer 68:1673–1677 Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83:2730–2734. doi:10.1210/jcem.83.8.5007 Baris D, Gridley G, Ron E et al (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13:395–400. doi:10.1023/A:1015713732717 Terzolo M, Reimondo G, Gasperi M et al (2005) Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 90:84–90. doi:10.1210/jc.2004-0240 Kauppinen-Mäkelin R, Sane T, Välimäki MJ et al (2010) Increased cancer incidence in acromegaly—a nationwide survey. Clin Endocrinol (Oxf) 72:278–279. doi:10.1111/j.1365-2265.2009.03619.x Petroff D, Tönjes A, Grussendorf M et al (2015) the incidence of cancer among acromegaly patients: results from the German acromegaly registry. J Clin Endocrinol Metab 100:3894–3902. doi:10.1210/jc.2015-2372 Renehan AG, Odwyer ST, Shalet SM (2001) Screening colonoscopy for acromegaly in perspective. Clin Endocrinol (Oxf) 55:731–733